PULMOCIDE LIMITED

Active London

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PULMOCIDE LIMITED

Research and experimental development on biotechnology

Founded 23 Mar 2007 Active London, England 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation
Net assets £22M £9M 2024 year on year
Total assets £25M £5M 2024 year on year
Total Liabilities £4M £4M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Office Suite 3.01 44 Southampton Buildings London WC2A 1AP England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PULMOCIDE LIMITED (06182024), an active life sciences and medical technology company based in London, England. Incorporated 23 Mar 2007. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£4.34M

Decreased by £3.83M (-47%)

Net Assets

£21.63M

Increased by £8.61M (+66%)

Total Liabilities

£3.66M

Decreased by £3.76M (-51%)

Turnover

N/A

Employees

9

Debt Ratio

14%

Decreased by 22 (-61%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (16)

Investor NameInvestor SinceParticipating Rounds
Investor 4Nov 2013Series B, Series C, Series A
Investor 16Nov 2013Series A
Investor 1Mar 2017Series B, Series C

Share Capital

Share Capital

Share allotments and capital structure

26 Allotments 234,936,791 Shares £6666.16m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Sept 20253,490,190£3.14m£0.9
19 Jun 202550,000£4k£0.075
18 Apr 2025306,250£23k£0.075
18 Apr 202570,303£6k£0.09
18 Apr 202523,017,711£20.72m£0.9

Officers

Officers

2 active 1 resigned
Status
James Robert MeyersDirectorAmericanUnited States6221 Sept 2021Active
Sabine Kohar DandiguianDirectorFrenchFrance6518 May 2021Active

Shareholders

Shareholders (72)

Jeito Slp
16.7%
40,154,504
Ip2ipo Portfolio (gp) Limited
6.3%
15,222,221

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

PULMOCIDE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Jan 2026CapitalAllotment of shares (GBP 2,444,896.68) on 2025-09-29
29 Jul 2025AccountsAnnual accounts made up to 2024-12-31
7 Jul 2025IncorporationMemorandum Articles
7 Jul 2025ResolutionResolutions
3 Jul 2025OfficersAppointment of Mr Jason Raleigh Nunn as director
20 Jan 2026 Capital

Allotment of shares (GBP 2,444,896.68) on 2025-09-29

29 Jul 2025 Accounts

Annual accounts made up to 2024-12-31

7 Jul 2025 Incorporation

Memorandum Articles

7 Jul 2025 Resolution

Resolutions

3 Jul 2025 Officers

Appointment of Mr Jason Raleigh Nunn as director

Recent Activity

Latest Activity

Allotment of shares (GBP 2,444,896.68) on 2025-09-29

2 months ago on 20 Jan 2026

Annual accounts made up to 2024-12-31

8 months ago on 29 Jul 2025

Memorandum Articles

9 months ago on 7 Jul 2025

Resolutions

9 months ago on 7 Jul 2025

Appointment of Mr Jason Raleigh Nunn as director

9 months ago on 3 Jul 2025